Affinity DataEC50: 185nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 180nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 306nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 303nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 1.14E+3nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 591nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 185nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 317nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 346nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 1.74E+3nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 1.77E+3nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 4.68E+3nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 846nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 1.49E+3nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 702nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 512nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 99nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 129nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 901nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 394nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 869nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 272nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 986nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 385nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 313nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 188nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 342nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 372nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 919nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 385nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 280nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 83nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 423nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 365nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 354nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 440nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 569nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 71nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 207nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 759nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 217nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 321nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 64.5nMAssay Description:Human PKM2 was diluted into Assay Buffer comprising 50 mM imidazole, 50 mM KCl, 7 mM MgCl2, 0.01% Tween20, 0.05% BSA (pH 7.2) to a final concentratio...More data for this Ligand-Target Pair
Affinity DataEC50: 92nMAssay Description:Activation of recombinant human PKM2 expressed in Escherichia coli BL21 at 4 uM incubated for 50 mins measured over 40 minsMore data for this Ligand-Target Pair
Affinity DataEC50: 6nMAssay Description:Activation of recombinant human PKM2 expressed in Escherichia coli BL21 at 4 uM incubated for 50 mins measured over 40 minsMore data for this Ligand-Target Pair
Affinity DataEC50: 7.10nMAssay Description:Activation of PKM2 (unknown origin) in presence of sorafenibMore data for this Ligand-Target Pair
Affinity DataEC50: 7.15E+3nMAssay Description:Activation of PKM2 (unknown origin) by pyruvate kinase-lactate dehydrogenase coupled assayMore data for this Ligand-Target Pair
Affinity DataEC50: 6.11E+3nMAssay Description:Activation of PKM2 (unknown origin) by pyruvate kinase-lactate dehydrogenase coupled assayMore data for this Ligand-Target Pair
Affinity DataEC50: 5.69E+3nMAssay Description:Activation of PKM2 (unknown origin) by pyruvate kinase-lactate dehydrogenase coupled assayMore data for this Ligand-Target Pair
Affinity DataEC50: 8.17E+3nMAssay Description:Activation of PKM2 (unknown origin) by pyruvate kinase-lactate dehydrogenase coupled assayMore data for this Ligand-Target Pair
